These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6319608

  • 21. Na+ pump in renal tubular cells is regulated by endogenous Na+-K+-ATPase inhibitor from hypothalamus.
    Cantiello HF, Chen E, Ray S, Haupert GT.
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F574-80. PubMed ID: 2845805
    [Abstract] [Full Text] [Related]

  • 22. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain.
    Sancho JM.
    Clin Exp Hypertens; 1998 Oct; 20(5-6):535-42. PubMed ID: 9682909
    [Abstract] [Full Text] [Related]

  • 23. Ouabainlike factor in Milan hypertensive rats.
    Ferrandi M, Minotti E, Salardi S, Florio M, Bianchi G, Ferrari P.
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
    [Abstract] [Full Text] [Related]

  • 24. Fluoresceinyl-ethylenediamine-ouabain detects an acidic environment in the cardiac glycoside binding site of Na+/K+-ATPase.
    Brinkmann K, Linnertz H, Amler E, Lanz E, Herman P, Schoner W.
    Eur J Biochem; 1997 Oct 01; 249(1):301-8. PubMed ID: 9363783
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Purification and characterization of specific endogenous ouabainlike substance from bovine adrenal.
    Inagami T, Tamura M.
    Am J Med Sci; 1988 Apr 01; 295(4):400-5. PubMed ID: 2834953
    [Abstract] [Full Text] [Related]

  • 27. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
    Kramer HJ, Baecker A, Weiler E, Liddiard C.
    Klin Wochenschr; 1986 Aug 15; 64(16):760-6. PubMed ID: 3020314
    [Abstract] [Full Text] [Related]

  • 28. Glutamic acid 327 in the sheep alpha 1 isoform of Na+,K(+)-ATPase is a pivotal residue for cation-induced conformational changes.
    Johnson CL, Kuntzweiler TA, Lingrel JB, Johnson CG, Wallick ET.
    Biochem J; 1995 Jul 01; 309 ( Pt 1)(Pt 1):187-94. PubMed ID: 7619055
    [Abstract] [Full Text] [Related]

  • 29. Lysophosphatidylcholines containing polyunsaturated fatty acids were found as Na+, K+-ATPase inhibitors in acutely volume-expanded hog.
    Tamura M, Harris TM, Higashimori K, Sweetman BJ, Blair IA, Inagami T.
    Biochemistry; 1987 May 19; 26(10):2797-806. PubMed ID: 3038164
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Purification and functional characterization of a low-molecular-mass Na+, K+-ATPase inhibitor protein from rat brain cytosol.
    Bhattacharyya D, Sen PC.
    Eur J Biochem; 1997 Mar 15; 244(3):829-34. PubMed ID: 9108253
    [Abstract] [Full Text] [Related]

  • 32. Effects of vanadate on ouabain binding and inhibition of (Na+ + K+)-ATPase.
    Myers TD, Boerth RC, Post RL.
    Biochim Biophys Acta; 1979 Nov 16; 558(1):99-107. PubMed ID: 227460
    [Abstract] [Full Text] [Related]

  • 33. Isolation and identification of hemin as an endogenous Na+/K(+)-ATPase inhibitor from porcine blood cells.
    Yasuhara T, Mori M, Wakamatsu K, Kubo K.
    Biochem Biophys Res Commun; 1991 Jul 15; 178(1):95-103. PubMed ID: 1648917
    [Abstract] [Full Text] [Related]

  • 34. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis.
    Zhao N, Lo LC, Berova N, Nakanishi K, Tymiak AA, Ludens JH, Haupert GT.
    Biochemistry; 1995 Aug 08; 34(31):9893-6. PubMed ID: 7632688
    [Abstract] [Full Text] [Related]

  • 35. PGE2 inhibits Na-K-ATPase activity and ouabain binding in MDCK cells.
    Cohen-Luria R, Rimon G, Moran A.
    Am J Physiol; 1993 Jan 08; 264(1 Pt 2):F61-5. PubMed ID: 8381604
    [Abstract] [Full Text] [Related]

  • 36. Transport functions of the liver. Lack of correlation between hepatocellular ouabain uptake and binding to (Na+ + K+)-ATPase.
    Petzinger E, Fischer K.
    Biochim Biophys Acta; 1985 May 28; 815(3):334-40. PubMed ID: 2986694
    [Abstract] [Full Text] [Related]

  • 37. Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
    Tal DM, Karlish SJ.
    Mol Pharmacol; 1988 Sep 28; 34(3):245-9. PubMed ID: 2843743
    [Abstract] [Full Text] [Related]

  • 38. Correlation between catecholamine secretion from bovine isolated chromaffin cells and [3H]-ouabain binding to plasma membranes.
    Aunis D, García AG.
    Br J Pharmacol; 1981 Jan 28; 72(1):31-40. PubMed ID: 6164427
    [Abstract] [Full Text] [Related]

  • 39. Heterogeneity of ouabain specific binding sites and (Na+ + K+)-ATPase inhibition in microsomes from rat heart.
    Noel F, Godfraind T.
    Biochem Pharmacol; 1984 Jan 01; 33(1):47-53. PubMed ID: 6322793
    [Abstract] [Full Text] [Related]

  • 40. Ouabain-binding site of (Na+ + K+)-ATPase in right-side-out vesicles has not an externally accessible SH group.
    Scheiner-Bobis G, Zimmermann M, Kirch U, Schoner W.
    Eur J Biochem; 1987 Jun 15; 165(3):653-6. PubMed ID: 3036511
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.